In-vivo validation of VASCOVID device, a hybrid diffuse optical platform for the assessment of microvasculature health in the intensive care

  • Marta Zanoletti
  • , M. Atif Yaqub
  • , Caterina Amendola
  • , Mauro Buttafava
  • , Talyta Carteano
  • , Davide Contini
  • , Lorenzo Cortese
  • , Luc Demarteau
  • , Lorenzo Frabasile
  • , Claudia Nunzia Guadagno
  • , Tijl Houtbeckers
  • , Umut Karadeniz
  • , Sanathana Konugolu Venkata Sekar
  • , Michele Lacerenza
  • , Jacqueline Martínez García
  • , Jaume Mesquida
  • , Marco Pagliazzi
  • , Sharzad Parsa
  • , Diego Sanoja García
  • , Jakub Tomanik
  • Alessandro Torricelli, Alberto Tosi, Tessa Wageenar, Udo M. Weigel, Turgut Durduran

Research output: Contribution to conferencePaperpeer-review

Abstract

We present preliminary in-vivo validation of VASCOVID device, a hybrid diffuse optical platform designed for automatized microvasculature health assessment in the intensive care. The in-vivo validation was run on more than hundred subjects.

Original languageEnglish
Publication statusPublished - 2024
Event2024 Clinical and Translational Biophotonics, Translational 2024 - Part of Optica Biophotonics Congress: Biomedical Optic - Fort Lauderdale, United States
Duration: 7 Apr 202410 Apr 2024

Conference

Conference2024 Clinical and Translational Biophotonics, Translational 2024 - Part of Optica Biophotonics Congress: Biomedical Optic
Country/TerritoryUnited States
CityFort Lauderdale
Period7/04/2410/04/24

Fingerprint

Dive into the research topics of 'In-vivo validation of VASCOVID device, a hybrid diffuse optical platform for the assessment of microvasculature health in the intensive care'. Together they form a unique fingerprint.

Cite this